As filed with the Securities and Exchange Commission on April 10, 2003.
Registration No. 333-
--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
----------------------------------
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
BAXTER INTERNATIONAL INC.
-------------------------
(Exact name of registrant as specified in its charter)
Delaware 36-0781620
------------------------------- ------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
One Baxter Parkway
Deerfield, Illinois 60015
(847) 948-2000
---------------------------------------------------------------------------
(Address, including zip code of registrant's principal executive offices)
Baxter International Inc. 2001 Incentive Compensation Program
(Full title of the Plan)
--------------------------------------------------------------
Jan Stern Reed
Corporate Secretary and Associate General Counsel
Baxter International Inc.
One Baxter Parkway
Deerfield, Illinois 60015
(847) 948-2000
--------------------------------------------------------------
(Name, address, and telephone number,
including area code, of agent for service)
CALCULATION OF REGISTRATION FEE
--------------------------------------------------------------------------------------------------------------------------------
Title of Amount to be Proposed maximum Proposed maximum Amount of registration
securities to be registered registered (1) offering price per share aggregate offering price fee
--------------------------------------------------------------------------------------------------------------------------------
Common Stock, $1 par value 3,500,000 shares 18.85 (3) $ 65,975,000 $ 5,340
per share, including
Preferred Stock Purchase
Rights (2)
--------------------------------------------------------------------------------------------------------------------------------
(1) Pursuant to Rule 416, this registration statement also covers any
additional shares of common stock which may be issuable in connection with
any stock split, stock dividend or similar transaction.
(2) Rights initially are carried and traded with the Common Stock. The value
attributable to the Rights, if any, is reflected in the market price of the
Common Stock.
(3) Estimated solely for purposes of calculating the registration fee pursuant
to Rule 457(c) and (h), based upon the average of the high and low prices
of the Common Stock reported by the New York Stock Exchange on April 4,
2003.
EXPLANATORY STATEMENT
This Registration Statement is filed pursuant to General Instruction E to
Form S-8 by Baxter International Inc., a Delaware corporation (the "Company"),
in order to register 3,500,000 shares of Common Stock, which shares are in
addition to those previously registered on a Registration Statement on Form S-8
(File No. 333-62820) filed with the Securities and Exchange Commission (the
"Commission") on June 12, 2001 for issuance pursuant to the Baxter International
Inc. 2001 Incentive Compensation Program. The contents of such previously filed
Registration Statement (File No. 333-62820) are incorporated herein by
reference.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits
Exhibit Number Description
-------------- -----------
5 Opinion of Legal Counsel
23.1 Consent of PricewaterhouseCoopers LLP
23.2 Consent of Legal Counsel (included in Exhibit 5)
24 Power of Attorney (included in signature page)
S I G N A T U R E S
The Registrant. Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Deerfield, State of Illinois, on April 10, 2003.
BAXTER INTERNATIONAL INC.
By: /S/ Harry M. Jansen Kraemer, Jr.
----------------------------------
Harry M. Jansen Kraemer, Jr.
Chairman of the Board of Directors
and Chief Executive Officer
Each person whose signature appears below constitutes and appoints Harry M.
Jansen Kraemer, Jr. and Jan Stern Reed, and each of them, his or her true and
lawful attorney-in-fact and agent, with full power of substitution, for him or
her and in his or her name, place and stead, in any and all capacities, to sign
any and all amendments to this Registration Statement, and to file the same,
with all exhibits thereto and other documents in connection therewith, with the
Securities and Exchange Commission, granting unto such attorney-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done in and about the
premises, as fully to all intents and purposes as he or she might or could do in
person, hereby ratifying all that such attorneys-in-fact and agents, or any of
them or their or his or her substitute or substitutes, may lawfully do or cause
to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration
Statement has been signed below by the following persons in the capacities
indicated on April 10, 2003.
SIGNATURE TITLE
/S/ Harry M. Jansen Kraemer, Jr. Chairman of the Board of Directors and
---------------------------------- Chief Executive Officer
Harry M. Jansen Kraemer, Jr. (Principal Executive Officer)
/S/ Brian P. Anderson Senior Vice President and
---------------------------------- Chief Financial Officer
Brian P. Anderson (Principal Financial Officer and
Principal Accounting Officer)
/S/ Walter E. Boomer Director
----------------------------------
Walter E. Boomer
/S/ Pei-yuan Chia Director
----------------------------------
Pei-yuan Chia
/S/ John W. Colloton Director
----------------------------------
John W. Colloton
/S/ Susan Crown Director
-------------------------------------
Susan Crown
/S/ Gail D. Fosler Director
-------------------------------------
Gail D. Fosler
/S/ Joseph B. Martin, M.D., Ph.D. Director
-------------------------------------
Joseph B. Martin, M.D., Ph.D.
/S/ James R. Gavin III, M.D., Ph.D. Director
-------------------------------------
James R. Gavin, M.D., Ph.D.
/S/ Thomas T. Stallkamp Director
-------------------------------------
Thomas T. Stallkamp
/S/ Monroe E. Trout Director
-------------------------------------
Monroe E. Trout
/S/ Fred L. Turner Director
-------------------------------------
Fred L. Turne
EXHIBIT INDEX
Exhibit Number Description
-------------- -----------
5 Opinion of Legal Counsel
23.1 Consent of PricewaterhouseCoopers LLP
23.2 Consent of Legal Counsel (included in Exhibit 5)
24 Power of Attorney (included in signature page)